1. Home
  2. AAOI vs NAMS Comparison

AAOI vs NAMS Comparison

Compare AAOI & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Optoelectronics Inc.

AAOI

Applied Optoelectronics Inc.

HOLD

Current Price

$141.60

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$33.52

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAOI
NAMS
Founded
1997
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.5B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AAOI
NAMS
Price
$141.60
$33.52
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$66.80
$46.75
AVG Volume (30 Days)
12.1M
811.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
85.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$119.87
$17.96
Revenue Next Year
$129.84
$540.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.72
$15.82
52 Week High
$155.40
$42.00

Technical Indicators

Market Signals
Indicator
AAOI
NAMS
Relative Strength Index (RSI) 64.13 53.92
Support Level $26.00 $29.73
Resistance Level N/A $37.43
Average True Range (ATR) 14.47 1.77
MACD 3.49 0.36
Stochastic Oscillator 80.14 61.07

Price Performance

Historical Comparison
AAOI
NAMS

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: